Computed tomography in staging of patients with melanoma metastatic to the regional nodes

Annals of Surgical Oncology

Volumn 4, Issue 5, 1997, Pages 396-402

  Johnson, Timothy M ^a   Fader, Darrell J ^a   Chang, Alfred E ^a   Yahanda, Alan ^a   Smith II, John W ^a   Hamlet, K Renee ^a   Sondak, Vernon K ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Computed tomography staging: Stage III melanoma

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CHILD; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MALE; MELANOMA; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; RADIOGRAPHY; SKIN TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; SKIN NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031178983     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02305552     Document Type: Article

References (30)

1. Balch CM, Cascinelli N, Drzewiecki KT, Eldh J, MacKie RM, McCarthy WH, et al. A comparison of prognostic factors worldwide. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong S, eds. Cutaneous melanoma. Philadelphia: JB Lippincott, 1992: 188-99.
2. Cohen MH, Ketcham AS, Felix EL, Li SH, Tomaszewski MM, Costa J, Rabson AS, et al. Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Ann Surg 1977; 186:635-12.
3. Callery C, Cochran AJ, Roe DJ, Rees W, Nathanson SD, Benedetti JK, Elashoff RM, et al. Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes. Ann Surg 1982;196:69-75.
4. Calabro A, Singletary SE, Balch CM. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg 1989;124:1051-5.
5. Bevilacqua RG, Coit DG, Rogatko A, Younes RN, Breenan MF. Axillary dissection in melanoma: prognostic variables in node-positive patients. Ann Surg 1990;212:125-31.
6. Malignant melanoma of the skin (excluding eyelid). In: Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, eds. American Joint Committee on Cancer Manual for Staging of Cancer. Philadelphia: JB Lippincott, 1992:143-8.
7. Johnson TM, Smith JW II, Nelson BR, Chang AE. Current therapy for cutaneous melanoma. J Am Acad Dermatol 1995;32;689-707.
8. Balch CM, Soong S, Murad TM, Smith JW, Maddox WA, Durant JR. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol 1983;1:126-34.
9. Amer MH, Al-Sarraf M, Vaitkevicius VK. Clinical presentation, natural history and prognostic factors in advanced malignant melanoma. Surg Gynecol Obstet 1979;149:687-92.
10. Stehlin JS, Hills WJ, Rufino C. Disseminated melanoma: biologic behavior and treatment. Arch Surg 1967;94:495-501.
11. Buzaid AC, Sandler AB, Mani S, Curtis AM, Poo WJ, Bolongnia JL, Ariyan S, et al. Role of computed tomography in the staging of primary melanoma. J Clin Oncol 1993;11:638-13.
12. Khansur T, Sanders J, Das SK. Evaluation of staging work-up in malignant melanoma. Arch Surg 1989;124:847-9.
13. Roth JA, Eilber FR, Bennet LR, Morton DL. Radionuclide photo-scanning. Usefulness in preoperative evaluation in melanoma patients. Arch Surg 1975;110:1211-12.
14. Thomas JH, Panousopoulous D, Liesmann GE, Jewell WR, Preston DF. Scintiscans in the evaluation of patients with malignant melanoma. Surg Gynecol Obstet 1979;149:574-76.
15. Buzaid AC, Tinoco L, Ross MI, Legha SS, Benjamine RS. Role of computed tomography in the staging of patients with local-regional metastases of melanoma. J Clin Oncol 1995;13:2104-8.
16. Galicien JH, Sundaresan N, Arbit E, Passe S. Surgical treatment of single brain metastasis: factors associated with survival. Cancer 1980;45:381-6.
17. Brega K, Robinson WA, Winston K, Wittenberg W. Surgical treatment of brain metastases in malignant melanoma. Cancer 1990; 66:2105-10.
18. Rosenberg SA, Yang JC, Topalian SL, Schwartzentruber DJ, Weber JS, Parkinson DR, Seipp CA, et al. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin-2. JAMA 1994;271:907-13.
19. Rosenberg SA, Aebersold P, Cornetta K, Kasid A, Morgan RA, Moen RA, Moen R, et al. Gene transfer into humans; immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 1990;323:570-8.
20. Pockaj BA, Sherry RM, Wei JP, Yannelli JR, Carter CS, Letiman SF, Carasquillo JA, et al. Localization of 111 indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Cancer 1994;73:1731-7.
21. Nabel GJ, Nabel EG, Yang ZY, Fox BA, Plautz GE, Gao X, Huang L, et al. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci USA 1993;90:11307-11.
22. Vile RG, Hart IR. Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res 1993;53:3860-4.
23. Veronesi U, Adams J, Bandiera DC, Brennhovd O, Caceres E, Cascinelli N, Claudio F, et al. Delayed regional lymph node dissection in stage I malignant melanoma of the skin of the lower extremities. Cancer 1982;49:2420-30.
24. Sim FH, Taylor WF, Pritchard DJ, Soule EH. Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc 1986;61:697-705.
25. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
26. Morton DL, Wen DR, Foshag LJ, Essner R, Cochran A. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J Clin Oncol 1993;11:1751-6.
27. Krag DN, Meijer SJ, Weaver DL, Loggie BW, Harlow SP, Tanabe KK, Laughlin EH, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995;130:654-8.
28. Ross MI, Reintgen D, Balch CM. Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Semin Surg Oncol 1993; 9:219-23.
29. Reintgen D, Cruse CW, Wells K, Berman C, Fenske N, Glass F, Schroer K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994;220:759-67.
30. Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996;14:7-17.